Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis

Ker, C. G., Chen, H. Y., Juan, C. C., Tseng, C. S., Sun, M. S., Lo, H. W., Shih, T. F., & Lo, W. C. (2006). Expression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma Cell Lines and Patients. Formosan Journal of Surgery, 39(3), 126-132. https://doi.org/10.29833/FJS.200606.0003
Ng, H. M. (2009). Regulation of vascular endothelial growth factor by ginsenoside RG1 inhuman endothelial cells [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200016791
Amini, A., Moghaddam, S. M., Morris, D. L., & Pourgholami, M. H. (2012). Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application. Journal of Oncology, 2012(), 508-521-146. https://doi.org/10.1155/2012/540791
Cheung, N. (1998). Expression of vascular endothelial growth factor and its receptors in tumours [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200006321
Tan, C. Y. (2011). Than42 inhibits angiogenesis induced by vascular endothelial growth factor and its mechanism of action [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2011.00146